Healthcare - Biotechnology - NASDAQ - US
$ 28.09
-5.61 %
$ 1.96 B
Market Cap
-7.43
P/E
Price Target
Average
63.76%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
21.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Akero Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AKRO of $46 , with forecasts ranging from a low of $38 to a high of $56 .
AKRO Lowest Price Target
Wall Street Target
38 USD
35.28%
AKRO Average Price Target
Wall Street Target
46 USD
63.76%
AKRO Highest Price Target
Wall Street Target
56 USD
99.36%
REVENUE FORECAST
Revenue Forecast Chart AKRO
EBIT FORECAST
EBIT Forecast Chart AKRO
NET INCOME FORECAST
Net Income Chart AKRO